| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 3 | 2023 | 804 | 0.720 |
Why?
|
| Renin | 9 | 2017 | 637 | 0.510 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2023 | 3688 | 0.430 |
Why?
|
| Bed Rest | 7 | 2005 | 84 | 0.380 |
Why?
|
| Aldosterone | 8 | 2017 | 870 | 0.340 |
Why?
|
| Embolism | 2 | 2023 | 408 | 0.320 |
Why?
|
| Sodium, Dietary | 3 | 2017 | 416 | 0.300 |
Why?
|
| Piracetam | 3 | 2016 | 87 | 0.300 |
Why?
|
| Pyridones | 2 | 2023 | 707 | 0.290 |
Why?
|
| Drug Hypersensitivity | 4 | 2017 | 889 | 0.280 |
Why?
|
| Penicillins | 3 | 2017 | 384 | 0.260 |
Why?
|
| Computer-Assisted Instruction | 3 | 2016 | 363 | 0.260 |
Why?
|
| Atrial Fibrillation | 5 | 2023 | 5003 | 0.260 |
Why?
|
| Weightlessness Simulation | 4 | 2006 | 40 | 0.260 |
Why?
|
| Anticonvulsants | 6 | 2016 | 1907 | 0.250 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2017 | 131 | 0.250 |
Why?
|
| Preoperative Care | 5 | 2018 | 2237 | 0.250 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2022 | 519 | 0.250 |
Why?
|
| Seizures | 5 | 2016 | 2829 | 0.230 |
Why?
|
| Reminder Systems | 2 | 2021 | 370 | 0.230 |
Why?
|
| Anticoagulants | 7 | 2023 | 4582 | 0.230 |
Why?
|
| Renin-Angiotensin System | 5 | 2017 | 763 | 0.230 |
Why?
|
| Progesterone | 4 | 2010 | 772 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2019 | 2275 | 0.220 |
Why?
|
| Middle Aged | 94 | 2022 | 212833 | 0.220 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2017 | 287 | 0.220 |
Why?
|
| Diabetes Mellitus | 6 | 2018 | 5702 | 0.220 |
Why?
|
| Adult | 96 | 2022 | 213375 | 0.210 |
Why?
|
| Fertilization in Vitro | 5 | 2010 | 1283 | 0.210 |
Why?
|
| Hypotension, Orthostatic | 4 | 2006 | 258 | 0.200 |
Why?
|
| Multiple Sclerosis | 5 | 2022 | 3065 | 0.200 |
Why?
|
| Hypoglycemia | 4 | 2019 | 855 | 0.200 |
Why?
|
| Female | 117 | 2023 | 378808 | 0.200 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2010 | 281 | 0.200 |
Why?
|
| Cephalosporins | 3 | 2017 | 204 | 0.200 |
Why?
|
| Stroke | 5 | 2023 | 9898 | 0.190 |
Why?
|
| Abortion, Induced | 2 | 2019 | 441 | 0.190 |
Why?
|
| Male | 104 | 2021 | 348967 | 0.190 |
Why?
|
| Humans | 152 | 2023 | 739219 | 0.180 |
Why?
|
| Counseling | 3 | 2019 | 1526 | 0.180 |
Why?
|
| Latent Tuberculosis | 1 | 2022 | 223 | 0.180 |
Why?
|
| Abortion, Eugenic | 1 | 2019 | 41 | 0.170 |
Why?
|
| Tuberculosis | 2 | 2022 | 1892 | 0.170 |
Why?
|
| Vacuum Curettage | 1 | 2019 | 48 | 0.170 |
Why?
|
| Laxatives | 1 | 2019 | 87 | 0.170 |
Why?
|
| Gels | 2 | 2019 | 426 | 0.170 |
Why?
|
| Embryo Transfer | 3 | 2010 | 510 | 0.170 |
Why?
|
| Inpatients | 5 | 2019 | 2478 | 0.160 |
Why?
|
| Substantia Nigra | 1 | 2020 | 353 | 0.160 |
Why?
|
| Colonoscopy | 3 | 2021 | 1363 | 0.160 |
Why?
|
| Phenytoin | 2 | 2009 | 198 | 0.160 |
Why?
|
| Hospitals, General | 2 | 2021 | 744 | 0.160 |
Why?
|
| Angiotensin II | 6 | 2010 | 880 | 0.160 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2018 | 109 | 0.160 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2013 | 370 | 0.160 |
Why?
|
| Respiratory Therapy | 1 | 2018 | 133 | 0.160 |
Why?
|
| Labor, Induced | 1 | 2019 | 146 | 0.160 |
Why?
|
| Aged | 61 | 2021 | 162667 | 0.160 |
Why?
|
| Melatonin | 1 | 2003 | 719 | 0.160 |
Why?
|
| Hydrocortisone | 4 | 2004 | 1810 | 0.160 |
Why?
|
| beta 2-Microglobulin | 1 | 2018 | 316 | 0.150 |
Why?
|
| Neuroprotective Agents | 2 | 2016 | 940 | 0.150 |
Why?
|
| Lipocalins | 1 | 2018 | 170 | 0.150 |
Why?
|
| Cystatin C | 1 | 2018 | 250 | 0.150 |
Why?
|
| Observation | 1 | 2019 | 312 | 0.150 |
Why?
|
| Coronary Sinus | 1 | 2017 | 87 | 0.140 |
Why?
|
| Bradykinin | 1 | 2016 | 214 | 0.140 |
Why?
|
| Sweetening Agents | 1 | 2019 | 296 | 0.140 |
Why?
|
| Licensure | 1 | 2017 | 124 | 0.140 |
Why?
|
| Leukemia | 6 | 1987 | 1503 | 0.140 |
Why?
|
| Choroid Plexus Neoplasms | 1 | 2016 | 43 | 0.140 |
Why?
|
| Eye Pain | 1 | 2016 | 47 | 0.140 |
Why?
|
| Densitometry | 1 | 2016 | 156 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 1099 | 0.130 |
Why?
|
| Adaptation, Physiological | 4 | 2006 | 1310 | 0.130 |
Why?
|
| Angioedemas, Hereditary | 1 | 2016 | 91 | 0.130 |
Why?
|
| Carbon Monoxide | 1 | 2018 | 530 | 0.130 |
Why?
|
| Cacao | 2 | 2013 | 98 | 0.130 |
Why?
|
| Plasma Exchange | 1 | 2016 | 154 | 0.130 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 346 | 0.130 |
Why?
|
| Hyperglycemia | 2 | 2014 | 1357 | 0.130 |
Why?
|
| Cardiovascular Deconditioning | 2 | 2005 | 9 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2017 | 302 | 0.130 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2021 | 806 | 0.130 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 1637 | 0.130 |
Why?
|
| Eicosanoids | 1 | 2017 | 276 | 0.130 |
Why?
|
| Nurse Practitioners | 2 | 2016 | 270 | 0.130 |
Why?
|
| Blood Pressure | 8 | 2017 | 8553 | 0.130 |
Why?
|
| Retrospective Studies | 33 | 2021 | 76632 | 0.130 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 279 | 0.120 |
Why?
|
| Acetamides | 1 | 2016 | 248 | 0.120 |
Why?
|
| Pain Measurement | 2 | 2016 | 3419 | 0.120 |
Why?
|
| Thromboembolism | 1 | 2020 | 984 | 0.120 |
Why?
|
| Albuminuria | 1 | 2018 | 692 | 0.120 |
Why?
|
| Weightlessness | 2 | 2005 | 88 | 0.120 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2017 | 312 | 0.120 |
Why?
|
| Laryngeal Nerves | 1 | 2014 | 56 | 0.120 |
Why?
|
| Sepsis | 3 | 2018 | 2571 | 0.120 |
Why?
|
| Epilepsy | 4 | 2012 | 3289 | 0.120 |
Why?
|
| Hypertension | 7 | 2005 | 8430 | 0.120 |
Why?
|
| Endocrine System | 2 | 2005 | 112 | 0.120 |
Why?
|
| Vasoconstrictor Agents | 3 | 2017 | 642 | 0.120 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 578 | 0.120 |
Why?
|
| Patient Satisfaction | 4 | 2012 | 3382 | 0.120 |
Why?
|
| Ketorolac | 1 | 2013 | 76 | 0.110 |
Why?
|
| Air Ambulances | 1 | 2014 | 82 | 0.110 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2021 | 909 | 0.110 |
Why?
|
| Head-Down Tilt | 7 | 2006 | 64 | 0.110 |
Why?
|
| Adrenal Glands | 3 | 2001 | 546 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 4 | 2017 | 7134 | 0.110 |
Why?
|
| Glucose | 2 | 2019 | 4376 | 0.110 |
Why?
|
| Blood Glucose | 5 | 2019 | 6236 | 0.110 |
Why?
|
| Fatigue | 1 | 2020 | 1524 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 846 | 0.110 |
Why?
|
| Fibromyalgia | 3 | 2003 | 388 | 0.110 |
Why?
|
| Luteal Phase | 2 | 2010 | 147 | 0.110 |
Why?
|
| Blood Coagulation | 1 | 2019 | 1122 | 0.110 |
Why?
|
| Brain Waves | 1 | 2017 | 401 | 0.110 |
Why?
|
| Insulin | 3 | 2018 | 6568 | 0.110 |
Why?
|
| Osteoarthritis, Hip | 2 | 2010 | 410 | 0.110 |
Why?
|
| Ependymoma | 1 | 2016 | 333 | 0.110 |
Why?
|
| Patient Care Planning | 1 | 2018 | 918 | 0.110 |
Why?
|
| Osteoporosis, Postmenopausal | 4 | 2003 | 386 | 0.110 |
Why?
|
| Professional Competence | 1 | 2016 | 448 | 0.110 |
Why?
|
| Cystoscopy | 1 | 2012 | 130 | 0.110 |
Why?
|
| Bone Density | 6 | 2010 | 3470 | 0.110 |
Why?
|
| Allergy and Immunology | 1 | 2014 | 169 | 0.110 |
Why?
|
| Laryngoscopy | 2 | 2015 | 703 | 0.110 |
Why?
|
| Atovaquone | 1 | 2012 | 58 | 0.110 |
Why?
|
| Lipoxins | 2 | 2005 | 411 | 0.110 |
Why?
|
| Aged, 80 and over | 23 | 2019 | 57639 | 0.110 |
Why?
|
| Aspergillosis | 4 | 1987 | 235 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 4 | 2019 | 7274 | 0.100 |
Why?
|
| Surgical Procedures, Operative | 2 | 2014 | 1867 | 0.100 |
Why?
|
| Microglia | 1 | 2020 | 1248 | 0.100 |
Why?
|
| Ibuprofen | 1 | 2013 | 235 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 2 | 2017 | 873 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2615 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 746 | 0.100 |
Why?
|
| Lichen Planus, Oral | 1 | 2012 | 55 | 0.100 |
Why?
|
| Length of Stay | 5 | 2018 | 6294 | 0.100 |
Why?
|
| Automobile Driving | 1 | 2017 | 431 | 0.100 |
Why?
|
| Respiratory Insufficiency | 2 | 2018 | 1197 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2018 | 764 | 0.100 |
Why?
|
| Pneumocystis carinii | 1 | 2012 | 71 | 0.100 |
Why?
|
| Supratentorial Neoplasms | 2 | 2010 | 160 | 0.100 |
Why?
|
| Platelet Factor 4 | 1 | 2011 | 129 | 0.100 |
Why?
|
| Young Adult | 21 | 2019 | 56252 | 0.100 |
Why?
|
| Lupus Nephritis | 2 | 2005 | 311 | 0.100 |
Why?
|
| Positron-Emission Tomography | 3 | 2020 | 6247 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2017 | 817 | 0.100 |
Why?
|
| Agranulocytosis | 4 | 1987 | 100 | 0.100 |
Why?
|
| Spironolactone | 1 | 2014 | 378 | 0.100 |
Why?
|
| Carboplatin | 1 | 2014 | 799 | 0.100 |
Why?
|
| Injections, Intramuscular | 5 | 2013 | 546 | 0.100 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2011 | 114 | 0.100 |
Why?
|
| Intensive Care Units | 3 | 2020 | 3672 | 0.100 |
Why?
|
| Education | 1 | 2014 | 543 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 1819 | 0.090 |
Why?
|
| Plagiarism | 1 | 2010 | 22 | 0.090 |
Why?
|
| Drug Utilization | 1 | 2017 | 1181 | 0.090 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2012 | 244 | 0.090 |
Why?
|
| Treatment Outcome | 21 | 2022 | 62691 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2007 | 2372 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2184 | 0.090 |
Why?
|
| Vocal Cord Paralysis | 1 | 2014 | 265 | 0.090 |
Why?
|
| Double-Blind Method | 9 | 2022 | 11985 | 0.090 |
Why?
|
| Airway Management | 1 | 2014 | 324 | 0.090 |
Why?
|
| Warfarin | 1 | 2019 | 1484 | 0.090 |
Why?
|
| Vitamin D Deficiency | 3 | 2008 | 1327 | 0.090 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 2649 | 0.090 |
Why?
|
| Atrophy | 3 | 2022 | 1569 | 0.090 |
Why?
|
| Brain | 7 | 2022 | 26293 | 0.090 |
Why?
|
| Home Care Services | 1 | 2016 | 602 | 0.090 |
Why?
|
| Intubation, Intratracheal | 2 | 2015 | 1349 | 0.090 |
Why?
|
| Sound | 1 | 2012 | 259 | 0.090 |
Why?
|
| Patient Participation | 1 | 2019 | 1441 | 0.090 |
Why?
|
| Microcirculation | 1 | 2014 | 1284 | 0.090 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2010 | 113 | 0.090 |
Why?
|
| Premedication | 2 | 2009 | 257 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2018 | 5305 | 0.090 |
Why?
|
| Desensitization, Immunologic | 1 | 2014 | 483 | 0.090 |
Why?
|
| Flavonoids | 1 | 2012 | 443 | 0.090 |
Why?
|
| Skin Tests | 3 | 2017 | 611 | 0.090 |
Why?
|
| Boston | 7 | 2018 | 9314 | 0.090 |
Why?
|
| Insulin Resistance | 3 | 2017 | 3858 | 0.080 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2010 | 187 | 0.080 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 1998 | 664 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 821 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2019 | 2679 | 0.080 |
Why?
|
| Pre-Eclampsia | 2 | 2017 | 1194 | 0.080 |
Why?
|
| Analgesia | 1 | 2013 | 458 | 0.080 |
Why?
|
| Health Behavior | 1 | 2021 | 2624 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1603 | 0.080 |
Why?
|
| Uterine Hemorrhage | 1 | 2010 | 255 | 0.080 |
Why?
|
| Coronary Circulation | 1 | 2014 | 1572 | 0.080 |
Why?
|
| Radioimmunoassay | 2 | 2000 | 918 | 0.080 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 1574 | 0.080 |
Why?
|
| Thromboxane B2 | 2 | 2005 | 152 | 0.080 |
Why?
|
| Thyroidectomy | 1 | 2014 | 876 | 0.080 |
Why?
|
| Acetanilides | 2 | 2020 | 167 | 0.080 |
Why?
|
| Creatinine | 6 | 2018 | 1903 | 0.080 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 7626 | 0.080 |
Why?
|
| Femur Neck | 1 | 2010 | 309 | 0.080 |
Why?
|
| Hospitals, Teaching | 2 | 2010 | 1166 | 0.080 |
Why?
|
| Adolescent | 24 | 2019 | 85409 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2016 | 1818 | 0.080 |
Why?
|
| Beverages | 1 | 2013 | 816 | 0.080 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 601 | 0.080 |
Why?
|
| Risk Factors | 15 | 2023 | 71972 | 0.080 |
Why?
|
| Videotape Recording | 1 | 2009 | 350 | 0.080 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 1216 | 0.080 |
Why?
|
| Absorptiometry, Photon | 3 | 2010 | 1726 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 964 | 0.070 |
Why?
|
| Psychophysiologic Disorders | 1 | 2009 | 228 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 954 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2017 | 1458 | 0.070 |
Why?
|
| Time Factors | 14 | 2019 | 40040 | 0.070 |
Why?
|
| Consultants | 1 | 2007 | 53 | 0.070 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 391 | 0.070 |
Why?
|
| Allergens | 1 | 2014 | 1308 | 0.070 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1988 | 300 | 0.070 |
Why?
|
| Antigens, Fungal | 1 | 1987 | 70 | 0.070 |
Why?
|
| Paclitaxel | 1 | 2014 | 1701 | 0.070 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 381 | 0.070 |
Why?
|
| Hysterectomy | 1 | 2012 | 926 | 0.070 |
Why?
|
| Immobilization | 2 | 2006 | 236 | 0.070 |
Why?
|
| Nitrogen | 1 | 1988 | 342 | 0.070 |
Why?
|
| Potassium | 6 | 2010 | 1337 | 0.070 |
Why?
|
| Kidney | 6 | 2017 | 7141 | 0.070 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2008 | 181 | 0.070 |
Why?
|
| Catheter Ablation | 2 | 2011 | 2737 | 0.070 |
Why?
|
| Accidental Falls | 2 | 2019 | 1055 | 0.070 |
Why?
|
| Prospective Studies | 13 | 2021 | 53036 | 0.070 |
Why?
|
| Follow-Up Studies | 14 | 2018 | 38941 | 0.070 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 820 | 0.070 |
Why?
|
| Hip Fractures | 2 | 2008 | 953 | 0.070 |
Why?
|
| Leg | 3 | 2005 | 1106 | 0.070 |
Why?
|
| Sodium | 6 | 2010 | 1625 | 0.070 |
Why?
|
| Aerospace Medicine | 1 | 2006 | 81 | 0.070 |
Why?
|
| Aspergillus fumigatus | 1 | 1987 | 150 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2731 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2010 | 606 | 0.070 |
Why?
|
| Hemodynamics | 3 | 2005 | 4196 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3514 | 0.070 |
Why?
|
| Maps as Topic | 1 | 1984 | 17 | 0.060 |
Why?
|
| Massachusetts | 4 | 2020 | 8668 | 0.060 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 3 | 2010 | 63 | 0.060 |
Why?
|
| Respiration | 1 | 2012 | 1645 | 0.060 |
Why?
|
| Intra-Abdominal Fat | 1 | 2010 | 590 | 0.060 |
Why?
|
| Needles | 1 | 2008 | 448 | 0.060 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 694 | 0.060 |
Why?
|
| Registries | 1 | 2020 | 8039 | 0.060 |
Why?
|
| Mammography | 1 | 2016 | 2466 | 0.060 |
Why?
|
| Hypoglycemic Agents | 2 | 2018 | 2861 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3844 | 0.060 |
Why?
|
| Carcinoma | 1 | 2016 | 2360 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2008 | 546 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 973 | 0.060 |
Why?
|
| Estradiol | 2 | 2010 | 2021 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2022 | 35274 | 0.060 |
Why?
|
| Heparin | 1 | 2011 | 1637 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2010 | 817 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 14721 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2216 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2009 | 544 | 0.060 |
Why?
|
| Systole | 2 | 2003 | 956 | 0.060 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 4214 | 0.060 |
Why?
|
| Reproducibility of Results | 6 | 2017 | 19787 | 0.060 |
Why?
|
| Angiotensinogen | 2 | 2001 | 163 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2019 | 23292 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2491 | 0.060 |
Why?
|
| Biometry | 1 | 2007 | 558 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2003 | 2015 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1170 | 0.060 |
Why?
|
| Clomiphene | 1 | 2003 | 72 | 0.060 |
Why?
|
| Pilot Projects | 5 | 2022 | 8272 | 0.060 |
Why?
|
| Body Composition | 2 | 2011 | 2396 | 0.060 |
Why?
|
| Plethysmography | 3 | 2012 | 180 | 0.060 |
Why?
|
| Postoperative Complications | 3 | 2018 | 15191 | 0.060 |
Why?
|
| Natriuresis | 1 | 2003 | 124 | 0.060 |
Why?
|
| Age Factors | 10 | 2010 | 18347 | 0.060 |
Why?
|
| Glia Maturation Factor | 1 | 2022 | 15 | 0.060 |
Why?
|
| Sex Factors | 7 | 2010 | 10397 | 0.060 |
Why?
|
| Aspirin | 2 | 2005 | 3268 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 2755 | 0.060 |
Why?
|
| Etidronic Acid | 1 | 2003 | 64 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3245 | 0.060 |
Why?
|
| Meningioma | 1 | 2012 | 1202 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2003 | 128 | 0.050 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 5632 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 8788 | 0.050 |
Why?
|
| Predictive Value of Tests | 6 | 2018 | 15035 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2014 | 1510 | 0.050 |
Why?
|
| Renal Circulation | 1 | 2003 | 333 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 3 | 2012 | 2546 | 0.050 |
Why?
|
| Meningeal Neoplasms | 1 | 2012 | 1234 | 0.050 |
Why?
|
| Syncope | 1 | 2005 | 431 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3143 | 0.050 |
Why?
|
| Internship and Residency | 3 | 2012 | 5761 | 0.050 |
Why?
|
| Critical Care | 1 | 2015 | 2624 | 0.050 |
Why?
|
| Bilirubin | 2 | 2017 | 415 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 2704 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3248 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2010 | 1670 | 0.050 |
Why?
|
| Pregnancy Rate | 3 | 2010 | 642 | 0.050 |
Why?
|
| Tuberculin Test | 1 | 2022 | 211 | 0.050 |
Why?
|
| Radiology | 1 | 2016 | 2080 | 0.050 |
Why?
|
| Teaching | 1 | 2009 | 1166 | 0.050 |
Why?
|
| France | 1 | 2003 | 516 | 0.050 |
Why?
|
| Appointments and Schedules | 2 | 2019 | 415 | 0.050 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2017 | 131 | 0.050 |
Why?
|
| Thyrotropin | 1 | 2005 | 849 | 0.050 |
Why?
|
| Neutropenia | 1 | 1987 | 888 | 0.050 |
Why?
|
| Immunoradiometric Assay | 1 | 2001 | 24 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 11666 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5833 | 0.050 |
Why?
|
| Weight Gain | 1 | 2011 | 2278 | 0.050 |
Why?
|
| Body Mass Index | 6 | 2017 | 12655 | 0.050 |
Why?
|
| Space Perception | 1 | 1984 | 474 | 0.050 |
Why?
|
| Mothers | 1 | 2012 | 2143 | 0.050 |
Why?
|
| Italy | 1 | 2003 | 827 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2003 | 739 | 0.050 |
Why?
|
| Fibrinolytic Agents | 2 | 2021 | 2149 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2001 | 176 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 3138 | 0.050 |
Why?
|
| Diastole | 1 | 2003 | 791 | 0.050 |
Why?
|
| Protective Clothing | 1 | 2021 | 102 | 0.050 |
Why?
|
| Penicillin G | 1 | 2000 | 42 | 0.050 |
Why?
|
| Cohort Studies | 8 | 2019 | 40385 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2011 | 11411 | 0.050 |
Why?
|
| Supine Position | 1 | 2001 | 210 | 0.050 |
Why?
|
| Antiviral Agents | 3 | 1998 | 2971 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 6963 | 0.050 |
Why?
|
| Prognosis | 8 | 2018 | 28901 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2009 | 1162 | 0.050 |
Why?
|
| Neurosyphilis | 1 | 2000 | 22 | 0.050 |
Why?
|
| Sex | 1 | 2000 | 57 | 0.050 |
Why?
|
| Heroin Dependence | 1 | 1981 | 175 | 0.050 |
Why?
|
| Pregnancy | 9 | 2019 | 29003 | 0.050 |
Why?
|
| Emergency Medicine | 1 | 2009 | 1201 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 3510 | 0.050 |
Why?
|
| Sunscreening Agents | 1 | 2021 | 132 | 0.050 |
Why?
|
| Lung Diseases, Fungal | 3 | 1985 | 122 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2008 | 1145 | 0.050 |
Why?
|
| Acyclovir | 2 | 1998 | 272 | 0.040 |
Why?
|
| Kidney Transplantation | 2 | 2012 | 4220 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4454 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2012 | 3180 | 0.040 |
Why?
|
| Energy Intake | 1 | 1988 | 2135 | 0.040 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15510 | 0.040 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2000 | 238 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2010 | 2582 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 5272 | 0.040 |
Why?
|
| Ceftriaxone | 1 | 2000 | 167 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2022 | 1778 | 0.040 |
Why?
|
| Carboxyhemoglobin | 1 | 2018 | 79 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2010 | 2048 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 879 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2009 | 5941 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2018 | 6570 | 0.040 |
Why?
|
| Collagen | 2 | 2005 | 2669 | 0.040 |
Why?
|
| Public Opinion | 1 | 1982 | 473 | 0.040 |
Why?
|
| Heart | 1 | 2012 | 4448 | 0.040 |
Why?
|
| Quality of Health Care | 2 | 2012 | 4365 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 1146 | 0.040 |
Why?
|
| General Surgery | 1 | 2009 | 1630 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 57 | 0.040 |
Why?
|
| Infusions, Intravenous | 3 | 2018 | 2270 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2003 | 683 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2012 | 6133 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 1986 | 2760 | 0.040 |
Why?
|
| Thrombosis | 1 | 2011 | 2962 | 0.040 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 20672 | 0.040 |
Why?
|
| Cysts | 1 | 2003 | 674 | 0.040 |
Why?
|
| Infant Formula | 1 | 2019 | 199 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 831 | 0.040 |
Why?
|
| Foscarnet | 1 | 1997 | 38 | 0.040 |
Why?
|
| Premenopause | 3 | 2011 | 1028 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 85 | 0.040 |
Why?
|
| Zona Glomerulosa | 1 | 2017 | 85 | 0.040 |
Why?
|
| Hyperparathyroidism | 1 | 1999 | 339 | 0.040 |
Why?
|
| South Africa | 1 | 2022 | 1743 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2009 | 2275 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 1994 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2019 | 365 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 446 | 0.040 |
Why?
|
| Venous Thromboembolism | 1 | 2009 | 1673 | 0.040 |
Why?
|
| Incidence | 4 | 2022 | 20912 | 0.040 |
Why?
|
| Observer Variation | 1 | 2003 | 2587 | 0.040 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1997 | 58 | 0.040 |
Why?
|
| Organothiophosphorus Compounds | 2 | 1986 | 15 | 0.040 |
Why?
|
| Amifostine | 2 | 1986 | 41 | 0.040 |
Why?
|
| Parathyroidectomy | 1 | 1999 | 234 | 0.040 |
Why?
|
| Hyperaldosteronism | 1 | 2000 | 234 | 0.040 |
Why?
|
| Diuretics | 2 | 2014 | 590 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 235 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 440 | 0.040 |
Why?
|
| Putamen | 1 | 2017 | 291 | 0.040 |
Why?
|
| Trifluridine | 1 | 1996 | 29 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2012 | 4671 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1997 | 259 | 0.030 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1999 | 358 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 2017 | 253 | 0.030 |
Why?
|
| Ependyma | 1 | 2016 | 56 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2019 | 732 | 0.030 |
Why?
|
| Parathyroid Hormone | 2 | 2000 | 1799 | 0.030 |
Why?
|
| Partial Thromboplastin Time | 1 | 2017 | 203 | 0.030 |
Why?
|
| Case-Control Studies | 6 | 2017 | 21691 | 0.030 |
Why?
|
| Valine | 1 | 1998 | 413 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 370 | 0.030 |
Why?
|
| Bicarbonates | 1 | 2017 | 312 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 1865 | 0.030 |
Why?
|
| Thyroid Nodule | 1 | 2003 | 750 | 0.030 |
Why?
|
| Aging | 4 | 2010 | 8607 | 0.030 |
Why?
|
| Self Administration | 1 | 2016 | 386 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 845 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2005 | 2263 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2003 | 1457 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 664 | 0.030 |
Why?
|
| Hormones | 1 | 1999 | 880 | 0.030 |
Why?
|
| Glioma | 1 | 2010 | 3378 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 1986 | 2564 | 0.030 |
Why?
|
| Education, Medical | 1 | 2007 | 1712 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1999 | 702 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2140 | 0.030 |
Why?
|
| Automation | 1 | 2017 | 582 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2017 | 568 | 0.030 |
Why?
|
| Cyclophosphamide | 3 | 2011 | 2238 | 0.030 |
Why?
|
| Hydrochlorothiazide | 1 | 2014 | 99 | 0.030 |
Why?
|
| Oncology Service, Hospital | 1 | 2014 | 57 | 0.030 |
Why?
|
| Drug Tolerance | 2 | 2008 | 376 | 0.030 |
Why?
|
| Reference Values | 3 | 2010 | 4981 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 708 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 2017 | 337 | 0.030 |
Why?
|
| Allied Health Personnel | 1 | 2015 | 161 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 592 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1893 | 0.030 |
Why?
|
| Institutionalization | 1 | 1994 | 104 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 806 | 0.030 |
Why?
|
| Bone Marrow | 1 | 1984 | 2933 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1997 | 624 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 2014 | 163 | 0.030 |
Why?
|
| Norepinephrine | 2 | 2010 | 911 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 975 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 2019 | 25470 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 848 | 0.030 |
Why?
|
| Attitude to Health | 1 | 1982 | 2047 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2017 | 591 | 0.030 |
Why?
|
| Standard of Care | 1 | 2017 | 563 | 0.030 |
Why?
|
| Herpes Simplex | 1 | 1996 | 466 | 0.030 |
Why?
|
| Anesthesia | 1 | 2004 | 1543 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4935 | 0.030 |
Why?
|
| Cognition | 2 | 2013 | 6686 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 2 | 2005 | 610 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 369 | 0.030 |
Why?
|
| Enalapril | 1 | 2014 | 323 | 0.030 |
Why?
|
| Epinephrine | 2 | 2010 | 795 | 0.030 |
Why?
|
| Cytokines | 2 | 2017 | 7296 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2014 | 840 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 24711 | 0.030 |
Why?
|
| Neck | 1 | 2016 | 691 | 0.030 |
Why?
|
| Professional Practice | 1 | 2014 | 327 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15069 | 0.030 |
Why?
|
| Homes for the Aged | 1 | 1994 | 260 | 0.030 |
Why?
|
| Adiponectin | 1 | 2017 | 1097 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 235 | 0.020 |
Why?
|
| Thalamus | 1 | 2017 | 1019 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8274 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1998 | 808 | 0.020 |
Why?
|
| Postmenopause | 4 | 2003 | 2456 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2248 | 0.020 |
Why?
|
| Recovery of Function | 3 | 2008 | 2924 | 0.020 |
Why?
|
| Hyperemia | 1 | 2012 | 224 | 0.020 |
Why?
|
| Pruritus | 1 | 2014 | 352 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2016 | 40801 | 0.020 |
Why?
|
| Myoglobin | 1 | 2011 | 160 | 0.020 |
Why?
|
| Behavior | 1 | 1994 | 561 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2019 | 1333 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1986 | 4214 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 2275 | 0.020 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2010 | 55 | 0.020 |
Why?
|
| Progesterone Congeners | 1 | 2010 | 42 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 11699 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2014 | 378 | 0.020 |
Why?
|
| Communication Aids for Disabled | 1 | 2010 | 56 | 0.020 |
Why?
|
| Apnea | 1 | 2012 | 196 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 839 | 0.020 |
Why?
|
| Biopsy | 3 | 2012 | 6722 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2000 | 3194 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1997 | 1269 | 0.020 |
Why?
|
| Ureter | 1 | 2012 | 361 | 0.020 |
Why?
|
| Video Recording | 1 | 2015 | 936 | 0.020 |
Why?
|
| Manometry | 1 | 2012 | 440 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2010 | 326 | 0.020 |
Why?
|
| Hexokinase | 1 | 2010 | 126 | 0.020 |
Why?
|
| Back Pain | 1 | 2014 | 540 | 0.020 |
Why?
|
| Bradycardia | 1 | 2012 | 305 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 3021 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2013 | 3909 | 0.020 |
Why?
|
| Infant | 3 | 2016 | 34923 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2010 | 337 | 0.020 |
Why?
|
| Foreign Medical Graduates | 1 | 2010 | 79 | 0.020 |
Why?
|
| Veins | 2 | 2004 | 767 | 0.020 |
Why?
|
| Hematocrit | 1 | 2011 | 636 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2011 | 418 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2011 | 527 | 0.020 |
Why?
|
| Antineoplastic Agents | 3 | 2011 | 13622 | 0.020 |
Why?
|
| Corneal Diseases | 1 | 2016 | 600 | 0.020 |
Why?
|
| Patient Preference | 1 | 2016 | 881 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 4190 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1748 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2004 | 7861 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 1436 | 0.020 |
Why?
|
| Survival Rate | 2 | 2016 | 12760 | 0.020 |
Why?
|
| Aorta | 1 | 2017 | 2047 | 0.020 |
Why?
|
| Fluorouracil | 2 | 2011 | 1609 | 0.020 |
Why?
|
| Resuscitation | 1 | 2014 | 656 | 0.020 |
Why?
|
| United States | 4 | 2019 | 69568 | 0.020 |
Why?
|
| Telemetry | 1 | 2010 | 204 | 0.020 |
Why?
|
| Heart Failure | 2 | 2003 | 10793 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2017 | 1587 | 0.020 |
Why?
|
| Mass Screening | 2 | 2021 | 5265 | 0.020 |
Why?
|
| Child | 5 | 2016 | 77029 | 0.020 |
Why?
|
| Acute Disease | 5 | 1986 | 7127 | 0.020 |
Why?
|
| Social Environment | 1 | 1994 | 1014 | 0.020 |
Why?
|
| Electromyography | 1 | 2014 | 1389 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2017 | 1909 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2020 | 3440 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 591 | 0.020 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 13880 | 0.020 |
Why?
|
| Platelet Count | 1 | 2011 | 780 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2012 | 479 | 0.020 |
Why?
|
| Obesity | 1 | 2010 | 12641 | 0.020 |
Why?
|
| Linear Models | 1 | 2018 | 5946 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1988 | 116 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 864 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2010 | 392 | 0.020 |
Why?
|
| Methotrexate | 2 | 2011 | 1710 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2448 | 0.020 |
Why?
|
| Probability | 2 | 2003 | 2500 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1583 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1987 | 212 | 0.020 |
Why?
|
| Candidiasis | 1 | 1989 | 365 | 0.020 |
Why?
|
| Premature Birth | 1 | 2019 | 1702 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2011 | 978 | 0.020 |
Why?
|
| Fruit | 1 | 2012 | 1138 | 0.020 |
Why?
|
| Delirium | 1 | 2018 | 1604 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 2995 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 1957 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1986 | 170 | 0.020 |
Why?
|
| Vegetables | 1 | 2012 | 1178 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1585 | 0.020 |
Why?
|
| Body Water | 1 | 1988 | 342 | 0.020 |
Why?
|
| Software | 2 | 2012 | 4425 | 0.020 |
Why?
|
| Regression Analysis | 3 | 2010 | 6451 | 0.020 |
Why?
|
| Nursing Homes | 1 | 1994 | 1029 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 2 | 2010 | 2212 | 0.020 |
Why?
|
| Midodrine | 1 | 2006 | 22 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 7897 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6517 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 6478 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2012 | 1154 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 2917 | 0.020 |
Why?
|
| Hemophilia B | 1 | 1986 | 80 | 0.020 |
Why?
|
| Comorbidity | 3 | 2012 | 10362 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 704 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6870 | 0.020 |
Why?
|
| Tilt-Table Test | 1 | 2005 | 81 | 0.020 |
Why?
|
| Sclerosis | 1 | 2006 | 210 | 0.020 |
Why?
|
| Models, Biological | 2 | 2017 | 9598 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2000 | 2867 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 2117 | 0.020 |
Why?
|
| Leukopenia | 1 | 1986 | 207 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 1988 | 909 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2560 | 0.020 |
Why?
|
| Metoclopramide | 1 | 1985 | 50 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2005 | 10248 | 0.020 |
Why?
|
| Nurses | 1 | 2015 | 2455 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2007 | 272 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2017 | 4556 | 0.020 |
Why?
|
| Histology | 1 | 2004 | 17 | 0.020 |
Why?
|
| Physician-Patient Relations | 2 | 2012 | 3217 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1904 | 0.020 |
Why?
|
| Robotics | 1 | 2012 | 890 | 0.020 |
Why?
|
| Neoplasms | 5 | 1986 | 21499 | 0.020 |
Why?
|
| Hand Strength | 1 | 2008 | 441 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2011 | 2215 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 1898 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 1350 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1988 | 669 | 0.020 |
Why?
|
| Spatial Behavior | 1 | 1984 | 90 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2017 | 3286 | 0.020 |
Why?
|
| Family | 2 | 2005 | 3141 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 1413 | 0.020 |
Why?
|
| Endocrine Glands | 1 | 2004 | 102 | 0.020 |
Why?
|
| Maternal Age | 1 | 2007 | 803 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 717 | 0.010 |
Why?
|
| Self Report | 1 | 2015 | 3524 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2004 | 6720 | 0.010 |
Why?
|
| Prevalence | 3 | 2010 | 15152 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2006 | 681 | 0.010 |
Why?
|
| Nurse-Patient Relations | 1 | 2004 | 101 | 0.010 |
Why?
|
| Benzothiadiazines | 1 | 2003 | 32 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 329 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10939 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 1093 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 7689 | 0.010 |
Why?
|
| Hospitals | 1 | 2017 | 3916 | 0.010 |
Why?
|
| Vasomotor System | 1 | 2004 | 210 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2008 | 581 | 0.010 |
Why?
|
| Space Flight | 1 | 2005 | 181 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2121 | 0.010 |
Why?
|
| Body Weight | 2 | 2000 | 4659 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2010 | 928 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2012 | 2484 | 0.010 |
Why?
|
| HIV Infections | 2 | 2000 | 16763 | 0.010 |
Why?
|
| Hospitalization | 2 | 2019 | 10208 | 0.010 |
Why?
|
| Antibodies | 1 | 2011 | 2450 | 0.010 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2003 | 75 | 0.010 |
Why?
|
| Hemophilia A | 1 | 1986 | 350 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 3452 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2014 | 2711 | 0.010 |
Why?
|
| Health Personnel | 1 | 2016 | 3202 | 0.010 |
Why?
|
| Amlodipine | 1 | 2003 | 79 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2710 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4746 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1085 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 2005 | 942 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2005 | 487 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 2003 | 266 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2009 | 1205 | 0.010 |
Why?
|
| Laboratories, Hospital | 1 | 2004 | 194 | 0.010 |
Why?
|
| Kinetics | 1 | 2010 | 6473 | 0.010 |
Why?
|
| Control Groups | 1 | 1982 | 105 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20038 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2005 | 1528 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 251 | 0.010 |
Why?
|
| Medicine | 1 | 2010 | 930 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 2503 | 0.010 |
Why?
|
| Administration, Intravaginal | 1 | 2001 | 147 | 0.010 |
Why?
|
| Quality of Life | 2 | 2016 | 12640 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 392 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 2009 | 0.010 |
Why?
|
| Potassium, Dietary | 1 | 2001 | 96 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 1735 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 6391 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 1678 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 5717 | 0.010 |
Why?
|
| Arteries | 1 | 2006 | 1115 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4205 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2002 | 624 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2012 | 2089 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2016 | 3730 | 0.010 |
Why?
|
| Drug Evaluation | 3 | 1986 | 637 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 8919 | 0.010 |
Why?
|
| Odds Ratio | 2 | 2010 | 9846 | 0.010 |
Why?
|
| Cross Infection | 1 | 1989 | 1414 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2006 | 1034 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2005 | 670 | 0.010 |
Why?
|
| Psychological Theory | 1 | 1981 | 168 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2456 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8306 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2003 | 415 | 0.010 |
Why?
|
| Citric Acid | 1 | 2000 | 126 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2003 | 550 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3576 | 0.010 |
Why?
|
| Ovulation Induction | 1 | 2001 | 274 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 1720 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 686 | 0.010 |
Why?
|
| Homeostasis | 1 | 2010 | 3346 | 0.010 |
Why?
|
| Internal-External Control | 1 | 1981 | 362 | 0.010 |
Why?
|
| Logistic Models | 2 | 2005 | 13400 | 0.010 |
Why?
|
| Iron | 1 | 1988 | 1776 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 1985 | 1242 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2261 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2003 | 646 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2006 | 981 | 0.010 |
Why?
|
| Methadone | 1 | 1981 | 307 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11471 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 630 | 0.010 |
Why?
|
| Environment | 1 | 1984 | 1110 | 0.010 |
Why?
|
| Melanoma | 2 | 1988 | 5446 | 0.010 |
Why?
|
| Calcium | 2 | 2003 | 5739 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 1999 | 252 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3723 | 0.010 |
Why?
|
| Diphosphonates | 1 | 2003 | 624 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 10961 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4211 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 2069 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 1637 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6410 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 1238 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 3908 | 0.010 |
Why?
|
| Vitamin D | 2 | 2003 | 3197 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1999 | 647 | 0.010 |
Why?
|
| Prolactin | 1 | 1999 | 668 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1982 | 793 | 0.010 |
Why?
|
| Family Health | 1 | 2002 | 1281 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2004 | 830 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2008 | 2021 | 0.010 |
Why?
|
| Risk | 2 | 1986 | 9684 | 0.010 |
Why?
|
| Animals | 3 | 2017 | 168358 | 0.010 |
Why?
|
| Collagen Type I | 1 | 1999 | 577 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2881 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2000 | 1653 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1889 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 13006 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 4095 | 0.010 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2003 | 1557 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 3340 | 0.010 |
Why?
|
| Intermediate Care Facilities | 1 | 1994 | 9 | 0.010 |
Why?
|
| Demography | 1 | 1999 | 1650 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1987 | 3605 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19223 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1996 | 687 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1999 | 2296 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2010 | 6661 | 0.010 |
Why?
|
| Psychology, Social | 1 | 1994 | 51 | 0.010 |
Why?
|
| Philadelphia | 1 | 1994 | 262 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2865 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 860 | 0.010 |
Why?
|
| Motivation | 1 | 1982 | 1965 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 1994 | 193 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1999 | 1203 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 1999 | 1407 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2005 | 6425 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3071 | 0.010 |
Why?
|
| Mental Health | 1 | 1986 | 2946 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1994 | 649 | 0.010 |
Why?
|
| Birth Weight | 1 | 2000 | 2061 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 2602 | 0.010 |
Why?
|
| Safety | 1 | 1996 | 1185 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4331 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6364 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2003 | 4941 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2000 | 2039 | 0.010 |
Why?
|
| Skilled Nursing Facilities | 1 | 1994 | 368 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2003 | 2267 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2000 | 2789 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1982 | 2781 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12235 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 10140 | 0.010 |
Why?
|
| Pennsylvania | 1 | 1989 | 615 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 5108 | 0.000 |
Why?
|
| Hospitals, University | 1 | 1989 | 567 | 0.000 |
Why?
|
| Algorithms | 1 | 2008 | 13828 | 0.000 |
Why?
|
| Genotype | 1 | 2002 | 12950 | 0.000 |
Why?
|
| Catheters, Indwelling | 1 | 1989 | 422 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1988 | 589 | 0.000 |
Why?
|
| Peptides | 1 | 1999 | 4392 | 0.000 |
Why?
|
| Factor IX | 1 | 1986 | 76 | 0.000 |
Why?
|
| Actuarial Analysis | 1 | 1985 | 377 | 0.000 |
Why?
|
| Pleurisy | 1 | 1985 | 53 | 0.000 |
Why?
|
| Akathisia, Drug-Induced | 1 | 1985 | 67 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1985 | 313 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 1676 | 0.000 |
Why?
|
| Amphotericin B | 1 | 1985 | 137 | 0.000 |
Why?
|
| Inflammation | 1 | 2005 | 10531 | 0.000 |
Why?
|
| Paranasal Sinus Diseases | 1 | 1985 | 116 | 0.000 |
Why?
|
| Factor VIII | 1 | 1986 | 348 | 0.000 |
Why?
|
| Vomiting | 1 | 1986 | 622 | 0.000 |
Why?
|
| Mice | 1 | 2010 | 80995 | 0.000 |
Why?
|
| Prednisone | 1 | 1988 | 1560 | 0.000 |
Why?
|
| Communicable Disease Control | 1 | 1989 | 853 | 0.000 |
Why?
|
| Patient Transfer | 1 | 1989 | 763 | 0.000 |
Why?
|
| Computers | 1 | 1985 | 614 | 0.000 |
Why?
|
| Cough | 1 | 1985 | 552 | 0.000 |
Why?
|
| Respiratory Sounds | 1 | 1985 | 692 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1996 | 9132 | 0.000 |
Why?
|
| Cause of Death | 1 | 1991 | 3564 | 0.000 |
Why?
|
| Hypotension | 1 | 1986 | 881 | 0.000 |
Why?
|
| Disease Progression | 1 | 1997 | 13237 | 0.000 |
Why?
|
| Cisplatin | 1 | 1985 | 1615 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1986 | 3863 | 0.000 |
Why?
|
| Epidemiologic Methods | 1 | 1984 | 1364 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1987 | 1833 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1988 | 9124 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1985 | 1253 | 0.000 |
Why?
|
| Fever | 1 | 1985 | 1607 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1988 | 8605 | 0.000 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1987 | 3066 | 0.000 |
Why?
|
| Radiography | 1 | 1985 | 6997 | 0.000 |
Why?
|
| Palliative Care | 1 | 1986 | 3461 | 0.000 |
Why?
|
| Pain | 1 | 1985 | 4923 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1985 | 12945 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1985 | 3487 | 0.000 |
Why?
|